[1]
Ferreira, R. et al. 2021. Evaluation of clinical and pathological response factors to neoadjuvant chemotherapy in breast cancer patients. Mastology. 31, (Apr. 2021), 1–8. DOI:https://doi.org/10.29289/2594539420210005.